Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05162781 · ClinicalTrials.gov registry record · NA

Transferring Speed of Processing Gains to Everyday Cognitive Tasks After Stroke

A NA study of Stroke and Cognitive Dysfunction, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
82
Enrollment target
1
Study location

NCT05162781: Active NA study of Stroke and Cognitive Dysfunction, sponsored by University of Alabama at Birmingham.

NCT05162781 is a NA study of Stroke and Cognitive Dysfunction that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 82 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05162781, a NA study of Stroke and Cognitive Dysfunction, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
82 participants
Enrollment target
1
Study location

Study Summary

This study will compare two approaches to cognitive rehabilitation in adults with stroke with persistent, mild to moderate, cognitive impairment. Both approaches will feature a web-based computer "game" that trains cognitive processing speed, i.e., how quickly individuals process information that they receive through their senses. This training is termed Speed of Processing Training (SOPT). One approach will add (A) in-lab training on everyday activities with important cognitive components and (B) procedures designed to transfer improvements in cognition from the treatment setting to everyday life. This approach is termed Constraint-Induced Cognitive Therapy (CICT). The other approach will add (A) in-lab training on relaxation, healthy nutrition, and healthy sleep and (B) procedures designed to promote integration of these lifestyle changes into everyday life. This approach is termed Brain Fitness-Heath Education Lifestyle Program (BF-HELP). Both CICT and BF-HELP will involve 35 hours of training. Ten 1-hour sessions of SOPT will be scheduled in the home with training conducted independently by participants. Ten 2.5 hours of in-lab, face-to-face, therapist directed sessions will be scheduled. These sessions will feature a brief period of SOPT; the bulk of the sessions will be committed to in-lab training on the target behaviors and the procedures designed to promote transfer of therapeutic gains to daily life; The set of the latter procedures is termed the Transfer Package. To accommodate the demands of participants' other activities, training sessions will be permitted to be scheduled as tightly as every weekday over 2 weeks or as loosely as every other weekday or so over 4 weeks. Family caregivers in both groups will also receive training on how to best support participants in their therapeutic program. The study will also test if there is an advantage to placing follow-up phone calls after treatment ends. The purpose of the calls will be to support transition o

Primary Outcome

The Neuro-QOL assesses function in daily life in several domains; it is a widely used, validated, transdiagnostic, self-report measure. The development and use of the Neuro-QOL is supported by the National Institutes of Health. The component of the Neuro-QOL that assessed cognitive function will be used here. Items are rated by respondents using a five-point scale: 1 = not at all, 5 = very much. Higher scores indicate better function.

Interventions

  • BEHAVIORAL Speed of Processing Training
  • BEHAVIORAL Instrumental Activities of Daily Living In-lab Training
  • BEHAVIORAL Cognitive Transfer Packagke
  • BEHAVIORAL Family Caregiver Coaching
  • BEHAVIORAL Follow-up Phone Calls

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2022-06-09
Est. Completion 2027-02-28
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the registry record for NCT05162781 still lists

NCT05162781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 5 interventions - of which Speed of Processing Training is the first listed.

NCT05162781 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT05162781 about?

NCT05162781 is a clinical study titled "Transferring Speed of Processing Gains to Everyday Cognitive Tasks After Stroke". This study will compare two approaches to cognitive rehabilitation in adults with stroke with persistent, mild to moderate, cognitive impairment. Both approaches will feature a web-based computer "game" that trains cognitive processing speed, i.e., how quickly individuals process information that th...

What is the current status of trial NCT05162781?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 82 participants. The study started on 2022-06-09. Estimated completion is 2027-02-28.

What conditions does trial NCT05162781 study?

This clinical trial studies the following conditions: Stroke, Cognitive Dysfunction.

What interventions are being tested in trial NCT05162781?

The interventions under investigation include: Speed of Processing Training (BEHAVIORAL), Instrumental Activities of Daily Living In-lab Training (BEHAVIORAL), Cognitive Transfer Packagke (BEHAVIORAL), Family Caregiver Coaching (BEHAVIORAL), Follow-up Phone Calls (BEHAVIORAL).

Who is sponsoring clinical trial NCT05162781?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05162781 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05162781's enrollment target sits among peer trials

82 164th of 454 higher than 291 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03319901 · 82 participants · Phase 1

    Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

  • NCT03493425 · 82 participants · Phase 2

    Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

  • NCT04105270 · 82 participants · Phase 2

    RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

  • NCT04428658 · 82 participants · NA

    Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05162781, the US trial registry maintained by the National Library of Medicine. NCT05162781 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.